Laryngeal involvement of rhabdomyosarcoma in an adult

World Journal of Surgical Oncology

Volumn 1, Issue , 2003, Pages

  Abali, Hüseyin ^a   Aksoy, Sercan ^a   Sungur, Arzu ^a   Yalçin, Suayib ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Larynx; Metastatic; Primary; Rhabdomyosarcoma

Indexed keywords

AMINOTRANSFERASE; CARBOPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MESNA; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; DRUG WITHDRAWAL; HUMAN; HUMAN TISSUE; LARYNX CANCER; LIVER TOXICITY; MALE; RHABDOMYOSARCOMA; UPPER RESPIRATORY TRACT OBSTRUCTION;

EID: 33646217068     PISSN: 14777819     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7819-1-17     Document Type: Article

References (9)

1. Shaha AR, Patel S, Shaha D, Harrison LB: Head and neck cancer. In Clinical Oncology 1st edition, Edited by: Lenhard RE, Osteen RT, Gansler T. Atlanta: The American Cancer Society Inc 2001, 297-327.
2. Akyol MU, Sozeri B, Kucukali T, Ogretmenoglu O: Laryngeal pleomorphic rhabdomyosarcoma. Eur Arch Otorhinolaryngol 1998, 255:307-310.
3. Rinaldo A, Howard DJ, Ferlito A: Laryngeal chondrosarcoma: A 24-year experience at the Royal National Throat, Nose and Ear Hospital. Acta Otolaryngol 2000, 120:680-688.
4. Puxeddu R, Pelagatti CL, Ambu R: Colon adenocarcinoma metastatic to the larynx. Eur Arch Otorhinolaryngol 1997, 254:353-355.
5. Marcus KC: Pediatric solid tumors. In Clinical Oncology 1st edition Edited by: Lenhard RE, Osteen RT, Gansler T. Atlanta: The American Cancer Society Inc 2001, 577-609.
6. Gullu I, Yalcin S, Tekuzman G, Barista I, Alkis N, Celik I, Zengin N, Guler N, Kars A, Baltali E, et al.: High-dose ifosfamide by infusion with Mesna in advanced refractory sarcomas. Cancer Invest 1996, 14:239-42. [PMID: 8630686]
7. Barista I, Tekuzman G, Yalcin S, Gullu I, Guler N, Ozisik Y, Kars A, Celik I, Turker A, Altundag K, Zengin N, Uner A, Baltali E, Firat D: Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy. J Surg Onco 2000, 73:12-6.
8. Yalcin S, Gullu I, Barista I, Tekuzman G, Ozisik Y, Celik I, Kars A: Treatment of advanced refractory sarcomas with ifosfamide and etoposide combination chemotherapy. Cancer Invest 1998, 16:297-302.
9. Yalcin S, Barista I, Tekuzman G, Gullu I, Fyrat D: Dramatic response to ifosfamide, mesna and doxorubicine chemotherapy regimen in an adult with clear cell sarcoma of the kidney. Journal of Urology 1996, 155:224.